ReviewActa neurologica Belgica2024

Real-world effectiveness, safety and immunogenicity of ocrelizumab in turkish multiple sclerosis patients: a single-center experience for 4-year follow-up.

Tugba Erdogan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.